Potential Benefit of Curcumin Adjuvant Therapy to the Standard H. Pylori Eradication Therapy in Patients With Peptic Ulcer Disease

Asian Journal of Pharmaceutical and Clinical Research - India
doi 10.22159/ajpcr.2017.v10i5.17462
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Innovare Academic Sciences Pvt Ltd

Related search

Clarithromycin-Based Triple Therapy for Helicobacter Pylori Treatment in Peptic Ulcer Patients

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2010English

State of Acid-Producing Function of the Stomach in Patients With Helicobacter Pylori-Associated Gastroduodenal Ulcer Disease and No Response to Eradication Therapy

Medical Council
2018English

Floating Drug Delivery Systems for Eradication of Helicobacter Pylori in Treatment of Peptic Ulcer Disease

2014English

Helicobacter Pylori Infection and Peptic Ulcer Disease in Patients With Liver Cirrhosis

Korean Journal of Internal Medicine
Internal Medicine
2008English

Recurrence Rate of Helicobacter Pylori in Patients With Peptic Ulcer Five Years or More After Successful Eradication

Arquivos de Gastroenterologia
Gastroenterology
2016English

Advances in the Therapy of Bleeding Peptic Ulcer

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2018English

Campylobacter Pylori in Gastritis and Peptic Ulcer Disease

Gut
Gastroenterology
1990English

Helicobacter Pylori Isolated From Patients Who Later Failed H. Pylori Eradication Triple Therapy Readily Develop Resistance to Clarithromycin

Journal of Medical Microbiology
MedicineMicrobiology
2006English

Low Efficacy of an Ultra-Short Term, Once-Daily Dose Triple Therapy With Omeprazole, Azithromycin, and Secnidazole for Helicobacter Pylori Eradication in Peptic Ulcer

Revista do Hospital das Clínicas
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy